OPKO Health (OPK) Tops Q4 EPS by 3c, provides guidance
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.61 -4.73%
Revenue Growth %: -11.2%
Financial Fact:
Product sales: 20.57M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Revenue Growth %: -11.2%
Financial Fact:
Product sales: 20.57M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $148.5 million versus the consensus estimate of $139.76 million.
GUIDANCE:
OPKO Health sees Q1 2026 revenue of $125-140 million, versus the consensus of $130.8 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel (INTC) PT Lowered to $92 at Mizuho
- Quanex (NX) Tops Q3 EPS by 14c; Offers Guidance
- John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
